Inactive Instrument

Highlights Bavarian Nordic A/S CBOE EUROPE EQUITIES

Equities

DK0015998017

Real-time Estimate Cboe Europe Other stock markets 02:59:34 13/06/2024 pm IST
167.8 ^DKK	0.00%

31/05	Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine	MT
30/05	Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine	31/05	MT
Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children	30/05	MT
Bavarian Nordic A/S and Coalition for Epidemic Preparedness Innovations Partners to Advance Mpox Vaccination in Africa	30/05	CI
Bavarian Nordic A/S commences an Equity Buyback Plan, under the authorization approved on April 16, 2024.	08/05	CI
Bavarian Nordic A/S Provides Earnings Guidance for the Year 2024	08/05	CI
Bavarian Nordic A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine	30/04	MT
Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve	30/04	CI
Bavarian Nordic Starts US Rolling Submission Process for Chikungunya Vaccine Candidate	29/04	MT
Bavarian Nordic A/S Initiates Rolling Submission of Biologics License Application with FDA for Chikungunya Vaccine Candidate	29/04	CI
Bavarian Nordic A/S's Equity Buyback announced on May 9, 2023, has expired.	16/04	CI
Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults	13/03	MT
Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland	13/03	CI
Bavarian Nordic A/S Reports Earnings Results for the Full Year Ended December 31, 2023	06/03	CI
Bavarian Nordic A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03	CI
Bavarian Nordic A/S Announces Accelerated Assessment for the Upcoming Marketing Authorisation Application for CHIKV VLP	23/02	CI
Bavarian Nordic A/S Provides Revenue Guidance for the Year 2024	21/02	CI
Bavarian Nordic Confirms FY23 Revenue Growth Outlook	16/11	MT
Bavarian Nordic A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11	CI
Bavarian Nordic A/S Provides Earnings Guidance for the Year 2023	16/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bavarian Nordic A/S CBOE EUROPE EQUITIES

Equities

DK0015998017

Highlights

Filters